Mani Keita
Mani Keita is a Deloitte Center for Health Solutions manager, applied health researcher, and strategist focused on public health, health care, life sciences, health equity, and population-health research. She holds a PhD in Health Services Research and Policy from Johns Hopkins Bloomberg School of Public Health.
Brain Health Care Is Shifting From Late Treatment to Integrated Prevention
At an Aspen Ideas Festival panel, Arianna Huffington, Richard Isaacson and Wendy Bartie argued that brain health should be treated as an integrated prevention problem rather than a late-life specialty concern. Using Alzheimer’s, mental health, workplace stress and drug development as reference points, they made the case for earlier risk detection, more specific behavioral prescriptions, continued pharmaceutical innovation and care models that expand access. Their shared warning was that separating medicine from daily behavior, or innovation from access, leaves the central problem only partly addressed.
South Texas Longevity Project Could Reach 1 Million Residents
Methodist Healthcare Ministries chief executive Jaime Wesolowski and Blue Zones founder Dan Buettner argue that a longevity effort in South Texas should start from the Rio Grande Valley’s existing strengths, not from a deficit model. In an Aspen Ideas: Health session, they make the case that poverty, uninsurance, chronic disease, and infrastructure gaps coexist with family, faith, social connection, and food traditions that can support longer, healthier lives if local institutions change the environments shaping daily behavior. The project, initially imagined for one city, may expand to seven cities and reach at least 1 million people.
South Texas Cities Test Blue Zones Prevention at Million-Person Scale
Methodist Healthcare Ministries chief executive Jaime Wesolowski and Blue Zones founder Dan Buettner argue that South Texas can become a large-scale test of longevity work built around prevention rather than clinical care. In a session at Aspen Ideas: Health, they described a potential seven-city Rio Grande Valley effort that would use local institutions, city policy, food environments, walkability, faith groups and social networks to make healthier daily choices easier for roughly 1mn people. Their case is that the region’s severe chronic-disease burdens coexist with cultural assets — family, faith, connection and traditional foodways — that could be amplified rather than replaced.
GLP-1s Are Reshaping Consumer Spending and Employer Health Benefits
A panel at Aspen Ideas: Health argued that GLP-1 drugs are becoming an economic force well beyond pharmaceuticals, changing what households buy while forcing employers, insurers, public programs, pharmacy benefit managers and manufacturers to rethink access to expensive chronic-care medicines. PwC’s Ali Furman pointed to spending shifts in groceries, restaurants, apparel and travel; Eli Lilly’s Laura Steele described new direct-to-consumer and employer channels built around demand; and economist Kosali Simon cautioned that the benefits may not show up simply as lower medical costs.
Brain Health Care Is Moving From Late-Stage Treatment to Early Prevention
At Aspen Ideas: Health, Arianna Huffington, preventive neurologist Richard Isaacson and Bristol Myers Squibb executive Wendy Bartie argued that brain health should be treated as a lifelong continuum, not a late-life dementia problem or a separate mental-health category. Their case was that earlier risk detection, specific daily interventions such as sleep, exercise and nutrition, new medicines, and less fragmented systems of care need to work together. Bartie put the access test bluntly: innovation matters only if people can actually reach it.